2023 Cedars-Sinai Hematologic Malignancies and Cell Therapy Case Conference - 12/11/2023

Monday, December 11, 2023, 12:30 PM - 1:30 PM, Online, Los Angeles, CA


This CME activity will provide participants with a comprehensive update and treatment/management strategies for common and uncommon hematologic and oncologic conditions. Cases will be presented and discussed in terms of disease classification, treatment, new data and best practices for practicing physicians and members of the healthcare team. Typical format will start with case presentations, followed by Pathology presentation and then discussion among attendees.

Objective(s): 1 Recognize the mechanisms of hematologic and oncologic processes and disorders 2 Apply clinical knowledge in the diagnosis of hematologic and oncologic disorders 3 Discuss common and uncommon Hem/Onc cases and the optimal treatment or management strategies that could be applied in practice, based on new treatment paradigms and/or shared clinical experience
Location: Online
Specialties: Radiation Oncology, Radiology, Oncology, Pathology & Laboratory Medicine, Hematology

Faculty Disclosures:
Joseph C Lownik, MD (Nothing to disclose - 11/01/2023)
Barry E Rosenbloom, MD (Nothing to disclose - 11/01/2023)
Download Handout

1. Recognize the mechanisms of hematologic and oncologic processes and disorders
2. Apply clinical knowledge in the diagnosis of hematologic and oncologic disorders
3. Discuss common and uncommon Hem/Onc cases and the optimal treatment or management strategies that could be applied in practice, based on new treatment paradigms and/or shared clinical experience

Cedars-Sinai Medical Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statement
Cedars-Sinai Medical Center designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Non-Physician Attendance
A certificate of participation will be provided to other health care professionals requesting credits. Participants should ensure in advance that their credentialing or licensing organization accepts AMA PRA Category 1 Credits™.

For activity access and session related questions, please contact
     Email: [email protected]; [email protected]

For general CME questions, please contact 
     Email: [email protected] 

AMA PRA Category 1 Credit(s)™ (MD, DO) (1.00 hours), Non-Physician Attendance (RN, APRN, PA, PharmD and Others) (1.00 hours)

Mitigation of Relevant Financial Relationships

Cedars-Sinai adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CE activity, including faculty, planners, reviewers or others are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Date	Empty Column	Title
12/11/2023 12:30:00 PM	2023 Cedars-Sinai Hematologic Malignancies and Cell Therapy Case Conference - 12/11/2023 12/11/2023 12:30:00 PM 12/11/2023 1:30:00 PM 6 Online False MM/DD/YYYY	2023 Cedars-Sinai Hematologic Malignancies and Cell Therapy Case Conference - 12/11/2023 This CME activity will provide participants with a comprehensive update and treatment/management strategies for common and uncommon hematologic and oncologic conditions. Cases will be presented and discussed in terms of disease classification, treatment, new data and best practices for practicing physicians and members of the healthcare team. Typical format will start with case presentations, followed by Pathology presentation and then discussion among attendees. Objective(s): 1 Recognize the mechanisms of hematologic and oncologic processes and disorders 2 Apply clinical knowledge in the diagnosis of hematologic and oncologic disorders 3 Discuss common and uncommon Hem/Onc cases and the optimal treatment or management strategies that could be applied in practice, based on new treatment paradigms and/or shared clinical experience Location: Online Specialties: Radiation Oncology, Radiology, Oncology, Pathology & Laboratory Medicine, Hematology Faculty Disclosures: Joseph C Lownik, MD (Nothing to disclose - 11/01/2023) Barry E Rosenbloom, MD (Nothing to disclose - 11/01/2023) Download Handout Location: Online Specialties: Radiation Oncology, Radiology, Oncology, Pathology & Laboratory Medicine, Hematology